======= BACE2 =======
== Gene Information ==
* **Official Symbol**: BACE2
* **Official Name**: beta-secretase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=25825|25825]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y5Z0|Q9Y5Z0]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=BACE2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BACE2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605668|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves APP, between residues 690 and 691, leading to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C- terminal fragment which is later released by gamma-secretase. It has also been shown that it can cleave APP between residues 671 and 672. {ECO:0000269|PubMed:10591213, ECO:0000269|PubMed:11083922, ECO:0000269|PubMed:11423558, ECO:0000269|PubMed:15857888, ECO:0000269|PubMed:16816112}.
|Asp|
|negative regulation of amyloid precursor protein biosynthetic process|
|regulation of amyloid precursor protein biosynthetic process|
|negative regulation of glycoprotein biosynthetic process|
|dense core granule|
|negative regulation of glycoprotein metabolic process|
|astrocyte activation|
|amyloid-beta metabolic process|
|aspartic-type endopeptidase activity|
|membrane protein ectodomain proteolysis|
|peptide hormone processing|
|astrocyte development|
|membrane protein proteolysis|
|glial cell activation|
|regulation of glycoprotein biosynthetic process|
|neuroinflammatory response|
|regulation of glycoprotein metabolic process|
|astrocyte differentiation|
|amyloid-beta binding|
|glial cell development|
|protein processing|
|trans-Golgi network|
|glial cell differentiation|
|glucose homeostasis|
|carbohydrate homeostasis|
|hormone metabolic process|
|gliogenesis|
|protein maturation|
|endosome|
|inflammatory response|
|peptide metabolic process|
|regulation of hormone levels|
|protein catabolic process|
|cellular amide metabolic process|
|central nervous system development|
|Golgi apparatus|
|endoplasmic reticulum|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|cell activation|
|negative regulation of protein metabolic process|
|chemical homeostasis|
|proteolysis|
|defense response|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|neurogenesis|
|homeostatic process|
|cell development|
|organic substance catabolic process|
|membrane|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|1.93|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 12713
* **Expression level (log2 read counts)**: 1.16
{{:chemogenomics:nalm6 dist.png?nolink |}}